SG Americas Securities
IMVT icon

SG Americas Securities’s Immunovant IMVT Stock Holding History

SG Americas Securities’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Buy
24,920
+2,119
+9% +$64.6K ﹤0.01% 1905
2026
Q1 		$566K Sell
22,801
-22,847
-50% -$592K ﹤0.01% 2108
2025
Q4 		$1.16M Sell
45,648
-16,950
-27% -$378K ﹤0.01% 1895
2025
Q3 		$1.01M Buy
62,598
+54,570
+680% +$883K ﹤0.01% 1449
2025
Q2 		$128K Buy
+8,028
New +$121K ﹤0.01% 2525
2024
Q4 		– Sell
-15,944
Closed -$455K – 3352
2024
Q3 		$455K Sell
15,944
-14,758
-48% -$435K ﹤0.01% 1769
2024
Q2 		$811K Buy
30,702
+26,546
+639% +$755K ﹤0.01% 1420
2024
Q1 		$134K Sell
4,156
-25,781
-86% -$941K ﹤0.01% 2312
2023
Q4 		$1.26M Sell
29,937
-66,766
-69% -$2.46M 0.01% 901
2023
Q3 		$3.71M Buy
96,703
+50,795
+111% +$1.15M 0.04% 406
2023
Q2 		$871K Buy
45,908
+13,208
+40% +$246K 0.01% 1124
2023
Q1 		$507K Buy
32,700
+11,673
+56% +$203K 0.01% 1710
2022
Q4 		$373K Buy
21,027
+4,323
+26% +$54.4K ﹤0.01% 1762
2022
Q3 		$93K Sell
16,704
-5,918
-26% -$28.9K ﹤0.01% 2873
2022
Q2 		$88K Buy
+22,622
New +$97.7K ﹤0.01% 3162
2022
Q1 		– Sell
-15,032
Closed -$128K – 3201
2021
Q4 		$128K Sell
15,032
-12,717
-46% -$105K ﹤0.01% 2922
2021
Q3 		$241K Buy
+27,749
New +$250K ﹤0.01% 3102
2021
Q2 		– Sell
-90,479
Closed -$1.45M – 3034
2021
Q1 		$1.45M Buy
90,479
+86,126
+1,979% +$2.27M 0.01% 1270
2020
Q4 		$201K Sell
4,353
-2,689
-38% -$124K ﹤0.01% 2624
2020
Q3 		$248K Sell
7,042
-3,379
-32% -$102K ﹤0.01% 2031
2020
Q2 		$254K Buy
+10,421
New +$223K ﹤0.01% 2652

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SG Americas Securities's IMVT Position: Q2 2026 in Review

SG Americas Securities increased its Immunovant (IMVT) stake by 9.3% in Q2 2026, buying an estimated $64.6K and bringing the position to 24,920 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

SG Americas Securities first reported a position in IMVT in Q2 2020 and has held it in 21 quarters since. The position peaked at $3.71M in Q3 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • SG Americas Securities held 24,920 shares of Immunovant worth $960K as of Q2 2026.
  • SG Americas Securities bought 2,119 Immunovant shares in Q2 2026, an estimated $64.6K.
  • Immunovant made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1905 holding.
  • SG Americas Securities first reported a position in Immunovant in Q2 2020 and has held it in 21 quarters since.
  • SG Americas Securities's Immunovant position peaked at $3.71M in Q3 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.